Latest Breaking News On - Syndax pharmaceuticals stock performance - Page 4 : comparemela.com

Syndax Pharmaceuticals, Inc (NASDAQ:SNDX) Receives $36 00 Consensus Target Price from Brokerages

Syndax Pharmaceuticals, Inc (NASDAQ:SNDX) Receives $36 00 Consensus Target Price from Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesBriggs morrisonWilliam meurySecurities exchange commissionAmeritas investment partners incNews ratings for syndax pharmaceuticals dailySyndax pharmaceuticals stock performanceBoard of administration florida retirement systemAnalyst recommendations for syndax pharmaceuticalsSyndax pharmaceuticalsSyndax pharmaceuticals incManufacturers life insurance companySyndax pharmaceuticals company profileCommonwealth equity servicesGet free reportDirector briggs morrison

Syndax Pharmaceuticals (NASDAQ:SNDX) Coverage Initiated by Analysts at StockNews com

Syndax Pharmaceuticals (NASDAQ:SNDX) Coverage Initiated by Analysts at StockNews com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

William meuryBriggs morrisonSyndax pharmaceuticals stock performanceSyndax pharmaceuticalsWells fargo companyNuveen asset managementInstitutional investors weigh in on syndax pharmaceuticalsJpmorgan chase coSyndax pharmaceuticals company profileWorth venture partnersNews ratings for syndax pharmaceuticals dailyAnalyst recommendations for syndax pharmaceuticalsSyndax pharmaceuticals incFree reportModerate buyGet free report

Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target Lowered to $33 00 at JPMorgan Chase & Co

Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target Lowered to $33 00 at JPMorgan Chase & Co
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesWilliam meuryBriggs morrisonSyndax pharmaceuticals stock performanceManufacturers life insurance companyInstitutional investors weigh in on syndax pharmaceuticalsSyndax pharmaceuticals incSyndax pharmaceuticalsNews ratings for syndax pharmaceuticals dailyAmeritas investment partners incBoard of administration florida retirement systemAnalyst recommendations for syndax pharmaceuticalsJpmorgan chase coCommonwealth equity servicesFree reportModerate buy

Syndax Pharmaceuticals (NASDAQ:SNDX) Hits New 1-Year Low at $19 14

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) shares reached a new 52-week low on Monday . The stock traded as low as $19.14 and last traded at $19.20, with a volume of 34822 shares traded. The stock had previously closed at $19.76. Analyst Upgrades and Downgrades Several research firms have recently weighed in on […]

United statesBriggs morrisonWilliam meuryInsider transactions at syndax pharmaceuticalsNews ratings for syndax pharmaceuticals dailySecurities exchange commissionPrincipal financial group incSyndax pharmaceuticals stock performanceSyndax pharmaceuticals incSyndax pharmaceuticalsPublic employees retirement association of coloradoAmerican international group incSyndax pharmaceuticals company profileSwiss national bankGet free reportDirector william meury

Syndax Pharmaceuticals (NASDAQ:SNDX) Posts Earnings Results, Beats Expectations By $0 09 EPS

Syndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.64) EPS for the quarter, beating analysts’ consensus estimates of ($0.73) by $0.09, Briefing.com reports. During the same period in the previous year, the firm earned ($0.62) earnings per share. Syndax Pharmaceuticals Stock Performance Shares of Syndax Pharmaceuticals […]

William meuryBriggs morrisonSyndax pharmaceuticals incCommonwealth equity servicesSchonfeld strategic advisorsEarnings history for syndax pharmaceuticalsSyndax pharmaceuticals stock performanceSyndax pharmaceuticalsPricet rowe associates incSyndax pharmaceuticals company profileNews ratings for syndax pharmaceuticals dailyArrowstreet capital limited partnershipFred alger managementGet free reportDirector briggs morrisonDirector william meury